Marksans Pharma receives EIR from USFDA for New York facility

11 Feb 2020 Evaluate

Marksans Pharma has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its manufacturing facility Time-Cap Laboratories Inc. located at Farmingdale, New York, USA. The inspection at the company's facility was carried out from December 05, 2019 to December 18, 2019.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.


Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×